KR20210043024A - Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법 - Google Patents

Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법 Download PDF

Info

Publication number
KR20210043024A
KR20210043024A KR1020217010934A KR20217010934A KR20210043024A KR 20210043024 A KR20210043024 A KR 20210043024A KR 1020217010934 A KR1020217010934 A KR 1020217010934A KR 20217010934 A KR20217010934 A KR 20217010934A KR 20210043024 A KR20210043024 A KR 20210043024A
Authority
KR
South Korea
Prior art keywords
tissue
lgr
lgr6
cells
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020217010934A
Other languages
English (en)
Korean (ko)
Inventor
덴버 엠. 로크
Original Assignee
폴래러티티이, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56078499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20210043024(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 폴래러티티이, 인크. filed Critical 폴래러티티이, 인크.
Publication of KR20210043024A publication Critical patent/KR20210043024A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • A01N1/021—
    • A01N1/0221—
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/362—Skin, e.g. dermal papillae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020217010934A 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법 Ceased KR20210043024A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462086526P 2014-12-02 2014-12-02
US62/086,526 2014-12-02
US14/954,335 2015-11-30
US14/954,335 US10926001B2 (en) 2014-12-02 2015-11-30 Methods related to minimally polarized functional units
PCT/US2015/063114 WO2016089825A1 (en) 2014-12-02 2015-12-01 Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020187036618A Division KR20180136587A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법

Publications (1)

Publication Number Publication Date
KR20210043024A true KR20210043024A (ko) 2021-04-20

Family

ID=56078499

Family Applications (5)

Application Number Title Priority Date Filing Date
KR1020217010934A Ceased KR20210043024A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020187036619A Ceased KR20180136588A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020187036618A Ceased KR20180136587A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020177017887A Ceased KR20170098844A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020197028100A Ceased KR20190111167A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법

Family Applications After (4)

Application Number Title Priority Date Filing Date
KR1020187036619A Ceased KR20180136588A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020187036618A Ceased KR20180136587A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020177017887A Ceased KR20170098844A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법
KR1020197028100A Ceased KR20190111167A (ko) 2014-12-02 2015-12-01 Lgr4, lgr5 및 lgr6 발현 상피 줄기 세포를 사용한 조직 응용에서의 최소 극성화 기능 세포 미소응집체 유닛의 개발 및 사용 방법

Country Status (21)

Country Link
US (7) US10926001B2 (cg-RX-API-DMAC7.html)
EP (2) EP3227431B1 (cg-RX-API-DMAC7.html)
JP (3) JP6791854B2 (cg-RX-API-DMAC7.html)
KR (5) KR20210043024A (cg-RX-API-DMAC7.html)
CN (1) CN107250348B (cg-RX-API-DMAC7.html)
AU (3) AU2015355187C1 (cg-RX-API-DMAC7.html)
BR (1) BR112017011808A2 (cg-RX-API-DMAC7.html)
CA (1) CA2969707C (cg-RX-API-DMAC7.html)
CO (1) CO2017006640A2 (cg-RX-API-DMAC7.html)
CR (1) CR20170296A (cg-RX-API-DMAC7.html)
EA (1) EA201791125A1 (cg-RX-API-DMAC7.html)
GB (2) GB2569056B (cg-RX-API-DMAC7.html)
HK (1) HK1250515A1 (cg-RX-API-DMAC7.html)
IL (2) IL252613B (cg-RX-API-DMAC7.html)
MX (2) MX2017007243A (cg-RX-API-DMAC7.html)
MY (1) MY184931A (cg-RX-API-DMAC7.html)
NZ (2) NZ733433A (cg-RX-API-DMAC7.html)
PH (1) PH12017501009B1 (cg-RX-API-DMAC7.html)
SG (2) SG10201914058QA (cg-RX-API-DMAC7.html)
WO (1) WO2016089825A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201703907B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110913690A (zh) * 2017-03-14 2020-03-24 朱诺治疗学股份有限公司 用于低温储存的方法
CA3088129A1 (en) * 2018-01-26 2019-08-01 Polarityte, Inc. Composite-interfacing biomaterial accelerant substrate
WO2019148143A1 (en) * 2018-01-26 2019-08-01 Polarityte, Inc. Complex living interface-coordinated self-assembling materials (clicsam)
FR3082123B1 (fr) 2018-06-07 2020-10-16 Urgo Rech Innovation Et Developpement Pansement cellularise et son procede de fabrication
JP2024006681A (ja) * 2022-07-04 2024-01-17 学校法人近畿大学 生体材料
WO2025166131A1 (en) * 2024-02-01 2025-08-07 Board Of Regents, The University Of Texas System Compositions and methods for treating bone and muscle injuries

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040126881A1 (en) * 2002-09-06 2004-07-01 Vincent Ronfard Fibrin cell supports and methods of use thereof
WO2006008009A2 (en) 2004-07-23 2006-01-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with leucine-rich repeat-containing gpcr 6 (lgr6)
US20060154365A1 (en) 2004-08-30 2006-07-13 Anthony Ratcliffe Cultured three dimensional tissues and uses thereof
US8053559B2 (en) 2005-10-27 2011-11-08 Coloplast A/S Biodegradable scaffold with ECM material
US20100328320A1 (en) 2006-07-13 2010-12-30 Kerstna Juergen Medical information management in a patient information hub system
US8366723B2 (en) 2006-08-03 2013-02-05 Rassman Licensing, Llc Hair harvesting device and method with localized subsurface dermal fluid insertion
WO2008031767A1 (en) 2006-09-12 2008-03-20 Dkfz Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts Cell culture of keratinocytes under non-differentiating conditions
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
GB201111244D0 (en) 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
FI20095355A0 (fi) 2009-04-01 2009-04-01 Helsingin Yliopisto Regeneroituva aktiivinen matriisi ja sen käytöt
JP2012531185A (ja) 2009-06-25 2012-12-10 株式会社 資生堂 Aff‐4を指標とした抗白髪剤のスクリーニング方法
US20110130711A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
US20130101564A1 (en) 2010-06-30 2013-04-25 Jinxi Chen Method for preparing dermis tissue cells aggregation and uses thereof
GB201106395D0 (en) 2011-04-14 2011-06-01 Hubrecht Inst Compounds
JP6215216B2 (ja) 2011-10-27 2017-10-18 ウニヴェルジテート ライプチッヒ 毛包外毛根鞘からメラノサイトを誘導する方法および移植のための調製
JP6186997B2 (ja) 2012-08-07 2017-08-30 日油株式会社 塗布型帯電防止剤
US9655930B2 (en) 2012-10-01 2017-05-23 Aderans Research Institute, Inc. Compositions and methods for producing reconstituted skin
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
BR112015023261A2 (pt) 2013-03-14 2017-07-18 Massachusetts Inst Technology composições e métodos para expansão e cultura de células-tronco epiteliais
US9592257B2 (en) 2013-10-11 2017-03-14 MWV Cell, LLC Complete human skin organ generated from culture-expanded cells
CN103550828B (zh) * 2013-10-17 2016-01-27 中国科学院动物研究所 一种基于毛囊干细胞和硅凝胶敷料的皮肤重建方法
TWI548413B (zh) 2014-11-07 2016-09-11 國立臺灣大學 誘導毛囊新生的皮膚萃取物、組合物及其用途

Also Published As

Publication number Publication date
CR20170296A (es) 2018-01-25
EP3227431B1 (en) 2025-01-29
US11266765B2 (en) 2022-03-08
WO2016089825A1 (en) 2016-06-09
EP3227431A4 (en) 2019-01-02
AU2019240603B2 (en) 2023-02-09
GB201902819D0 (en) 2019-04-17
GB2549872A (en) 2017-11-01
GB201710646D0 (en) 2017-08-16
US20160151540A1 (en) 2016-06-02
PH12017501009A1 (en) 2017-12-11
US20190046691A1 (en) 2019-02-14
US20220241464A1 (en) 2022-08-04
AU2023202857A1 (en) 2023-05-25
BR112017011808A2 (en) 2018-02-27
KR20190111167A (ko) 2019-10-01
US11338060B2 (en) 2022-05-24
US20180154044A1 (en) 2018-06-07
NZ755260A (en) 2021-12-24
IL287488B2 (en) 2023-06-01
AU2015355187B2 (en) 2019-10-03
EP3227431A1 (en) 2017-10-11
CA2969707A1 (en) 2016-06-09
AU2015355187C1 (en) 2020-02-20
EP4438128A2 (en) 2024-10-02
US12465669B2 (en) 2025-11-11
EP4438128A3 (en) 2024-11-13
CN107250348A (zh) 2017-10-13
JP2020182880A (ja) 2020-11-12
AU2015355187A1 (en) 2017-06-29
HK1245327A1 (zh) 2018-08-24
SG10201914058QA (en) 2020-03-30
US10926001B2 (en) 2021-02-23
AU2019240603A1 (en) 2019-10-17
MX2017007243A (es) 2018-01-25
MY184931A (en) 2021-04-30
MX2023001655A (es) 2023-04-24
JP2017538411A (ja) 2017-12-28
HK1250515A1 (zh) 2018-12-21
GB2569056A (en) 2019-06-05
US11000629B2 (en) 2021-05-11
US20230181797A1 (en) 2023-06-15
CA2969707C (en) 2019-08-20
EP3227431C0 (en) 2025-01-29
CO2017006640A2 (es) 2017-11-21
EA201791125A1 (ru) 2018-06-29
US20210322643A1 (en) 2021-10-21
CN107250348B (zh) 2021-09-03
US20180154043A1 (en) 2018-06-07
JP6791854B2 (ja) 2020-11-25
ZA201703907B (en) 2023-03-29
GB2569056B (en) 2020-01-01
IL287488A (en) 2021-12-01
NZ733433A (en) 2019-08-30
JP2019088299A (ja) 2019-06-13
US11596714B2 (en) 2023-03-07
PH12017501009B1 (en) 2022-01-21
KR20180136587A (ko) 2018-12-24
IL252613B (en) 2021-12-01
KR20170098844A (ko) 2017-08-30
SG11201704502RA (en) 2017-06-29
KR20180136588A (ko) 2018-12-24
IL252613A0 (en) 2017-07-31

Similar Documents

Publication Publication Date Title
US12465669B2 (en) Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using LGR4, LGR5, and LGR6 expressing epithelial stem cells
Moshaverinia et al. Application of stem cells derived from the periodontal ligament or gingival tissue sources for tendon tissue regeneration
CN105517587B (zh) 伤口愈合与组织工程
Iqbal et al. Breathing new life into tissue engineering: exploring cutting-edge vascularization strategies for skin substitutes
Sun et al. Co-culture of outgrowth endothelial cells with human mesenchymal stem cells in silk fibroin hydrogels promotes angiogenesis
Yang et al. Engineering human ventricular heart tissue based on macroporous iron oxide scaffolds
JP2017538411A5 (cg-RX-API-DMAC7.html)
Qin et al. SDF-1α/BMP-12 loaded biphasic sustained-release SIS hydrogel/SA microspheres composite for tendon regeneration
CN120574767A (zh) 人胎盘源促血管干细胞hPASCs及其应用
KR20110032433A (ko) 세포이식술을 위한 혼합세포복합체인 세포스페로이드의 제조방법 및 이의 이용방법
HK1245327B (en) Methods for development and use of minimally polarized function cell micro-aggregate units in tissue applications using lgr4, lgr5 and lgr6 expressing epithelial stem cells
OA19578A (en) Methods for development and use of minimally polarized function cell microaggregate units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells
OA19580A (en) Methods for development and use of minimally polarized function cell microaggregate units in tissue applications using LGR4, LGR5 and LGR6 expressing epithelial stem cells
CN1901802B (zh) 用脂肪组织来源的细胞治疗心血管疾病的方法
Hohenberger et al. Mario Vitacolonna, Djeda Belharazem

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000